74 related articles for article (PubMed ID: 11420829)
1. [Insulin therapy in the type 2 obese diabetic patient. Supplementing the deficit].
Matthaei S; Häring HU
MMW Fortschr Med; 2001 May; 143(21):35-7. PubMed ID: 11420829
[TBL] [Abstract][Full Text] [Related]
2. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
[TBL] [Abstract][Full Text] [Related]
3. [When diet and oral antidiabetics are no longer enough. Optimal management of the diabetic patient with insulin].
Rosak C
MMW Fortschr Med; 2002 May; 144(18):28-30, 32, 34. PubMed ID: 12422704
[TBL] [Abstract][Full Text] [Related]
4. [New methods in insulin treatment].
Neuwirth G
Orv Hetil; 2005 Jan; 146(3):111-6. PubMed ID: 15693442
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of conversion from bedtime NPH insulin to morning insulin glargine in type 2 diabetic patients on basal-prandial insulin therapy.
Yokoyama H; Tada J; Kamikawa F; Kanno S; Yokota Y; Kuramitsu M
Diabetes Res Clin Pract; 2006 Jul; 73(1):35-40. PubMed ID: 16513202
[TBL] [Abstract][Full Text] [Related]
6. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
Rosak C; Haupt E; Walter T; Werner J
Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
[TBL] [Abstract][Full Text] [Related]
7. [Bedtime administration of metformin may reduce insulin requirements].
Ravina A; Minuchin O
Harefuah; 1990 Oct; 119(7-8):200-3. PubMed ID: 2258095
[TBL] [Abstract][Full Text] [Related]
8. [Step-wise drug therapy in type 2 diabetes mellitus].
König K; Schatz H
Z Arztl Fortbild Qualitatssich; 1998 Sep; 92(7):467-73. PubMed ID: 9842691
[TBL] [Abstract][Full Text] [Related]
9. Inhaled insulin as adjunctive therapy in subjects with type 2 diabetes failing oral agents: a controlled proof-of-concept study.
Hausmann M; Dellweg S; Osborn C; Heinemann L; Buchwald A; Rosskamp R; Genova P; Heise T
Diabetes Obes Metab; 2006 Sep; 8(5):574-80. PubMed ID: 16918593
[TBL] [Abstract][Full Text] [Related]
10. Dosing of insulin glargine in the treatment of type 2 diabetes.
Barnett A
Clin Ther; 2007 Jun; 29(6):987-99. PubMed ID: 17692716
[TBL] [Abstract][Full Text] [Related]
11. [Early control of diabetic sequelae. Combined insulin treatment also in type 2].
MMW Fortschr Med; 2000 Jun; 142(25):57. PubMed ID: 10920674
[No Abstract] [Full Text] [Related]
12. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
Yki-Järvinen H
Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
[TBL] [Abstract][Full Text] [Related]
13. Making the transition from oral to insulin therapy.
Riddle MC
Am J Med; 2005 May; 118 Suppl 5A():14S-20S. PubMed ID: 15850549
[TBL] [Abstract][Full Text] [Related]
14. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
Caballero AE
J Diabetes Complications; 2009; 23(2):143-52. PubMed ID: 18413192
[TBL] [Abstract][Full Text] [Related]
15. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
[TBL] [Abstract][Full Text] [Related]
16. Glimepiride pharmacokinetics in obese versus non-obese diabetic patients.
Shukla UA; Chi EM; Lehr KH
Ann Pharmacother; 2004 Jan; 38(1):30-5. PubMed ID: 14742789
[TBL] [Abstract][Full Text] [Related]
17. [Risks and side effects of intensified insulin therapy].
Honegger R; Spinas GA
Wien Med Wochenschr; 1997; 147(9):226-30. PubMed ID: 9281237
[TBL] [Abstract][Full Text] [Related]
18. [New trends in therapy of diabetes. More freedom, fewer risks, comfortable insulin administration].
Harsch IA; Hahn EG; Ficker JH
MMW Fortschr Med; 2000 Jul; 142(28-29):24-6. PubMed ID: 10959155
[TBL] [Abstract][Full Text] [Related]
19. Optimum insulin use in older diabetics.
Shuman CR
Geriatrics; 1984 Oct; 39(10):71-4, 79-84, 89. PubMed ID: 6383955
[TBL] [Abstract][Full Text] [Related]
20. [When and why start insulin in type 2 diabetes?].
Potier L
Rev Prat; 2015 Oct; 65(8):1042-5. PubMed ID: 26749702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
